Bristol Myers Squibb

OPDIVO

  1. Home
  2.  / 
  3. J Code
  4.  / OPDIVO – J9299

Manufacturer:

Bristol Myers Squibb

Name:

OPDIVO

HCPCS Code Descriptor:

Injection, nivolumab, 1 mg

Category:

J Code

HCPCS:

J9299

NDC(s):

00003-3772-11, 00003-3774-12, 00003-3756-14, 00003-3734-13

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

OPDIVO is an Oncology drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The J Code: J9299 is aligned to the drug OPDIVO.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/16

HCPCS Effective Date:

1/1/16

HCPCS Short Description:

Injection, nivolumab

Billing and Coding Guide:

https://www.bmsaccesssupport.bmscustomerconnect.com/servlet/servlet.FileDownload?file=00Pi000000nzXaoEAE

Patient Assistance:

https://www.bmsaccesssupport.bmscustomerconnect.com/patient

https://www.bmsaccesssupport.bmscustomerconnect.com/patient

OPDIVO - J9299